Through organoid drug sensitivity testing, we confirmed that the expression of ESPL1 was statistically linked with PHA-793887, PAC-1, and AZD-7762, and that the expression of ESPL1 in colorectal cancer patient tissues may indicate the use of these drugs. This evidence concerns the gene ESPL1 and colorectal cancer.